Although tumor-associated proteolytic activation <i>in vivo</i> is indicated, this does not contribute to tumor retention as judged from control experiments under pharmacological blockade of cathepsin B and with nonfunctional analogues. This evidence concerns the gene CTSB and neoplasm.